The Health Impacts of Anti-LGBTQ+ PoliciesHaving accessible and affordable healthcare is something that every person should have a right to. But members of the LGBTQ+ community often face challenges when it comes to accessing healthcare... By Editorial Team3 min readBookmark for laterReactions 0 reactions Comments1 comments
Importance of Exercise in People Living With HIVExercise may not be a priority if you are living with HIV, but it is essential for your health and well-being. There are many benefits for not only your body... By Editorial Team2 min readBookmark for laterReactions 0 reactions Comments2 comments
Criminalization of HIV Status in the United StatesHIV criminalization laws in the United States are under scrutiny from the United Nations (UN) and the White House. Criminalization is making certain behaviors illegal or treating a person who... By Editorial Team2 min readBookmark for laterReactions 0 reactions Comments3 comments
A Once-A-Week ART Trial with Lenacapavir and IslatravirResearch scientists are working together to see if a combination of medications - lenacapavir and islatravir - can improve HIV management. Both of these medications have a big advantage over... By Editorial Team3 min readBookmark for laterReactions 0 reactions Comments1 comments
ATN: Focus on Youth in HIV Prevention and TreatmentWe know that PrEP, PEP, and ART work really well to prevent and treat HIV. How do we get them to the people who need them? The Adolescent Medicine Trials... By Editorial Team3 min readBookmark for laterReactions 0 reactions Comments0 comments
Learning About HIV Viral Suppression: a Small StudyYou have probably seen the recent news about the "Esperanza patient." This person has been able to clear any measurable HIV in their cells for more than 8 years in... By Editorial Team3 min readBookmark for laterReactions 0 reactions Comments1 comments
New Tech Gives Hope for an HIV VaccineThe COVID-19 pandemic has focused attention on vaccines - in particular, the new type of vaccine based on messenger RNA, or mRNA. The first 2 vaccines to be available in... By Editorial Team3 min readBookmark for laterReactions 0 reactions Comments2 comments
Clinical Trial to Investigate EBT-101 as a Functional Cure for Chronic HIVThe human immunodeficiency virus (HIV) attacks cells in the immune system. If left untreated, HIV can lead to acquired immunodeficiency syndrome (AIDS). HIV is a retrovirus, which means it has... By Editorial Team3 min readBookmark for laterReactions 0 reactions Comments1 comments
Improving Premature Aging In People With HIV/AIDSWhile the aging process affects everyone, each person ages at a different rate. However, research shows that the aging process happens much faster in people with HIV.1 Premature aging in... By Editorial Team3 min readBookmark for laterReactions 0 reactions Comments1 comments
FDA Approves First Human Trials for HIV CureThe U.S. Food and Drug Administration (FDA) has approved the start of Phase 1 of the first human clinical trial for the gene therapy AGT103-T to cure HIV. AGT103-T is... By Editorial Team3 min readBookmark for laterReactions 0 reactions Comments2 comments
Immunotherapy: The Key to Developing an HIV Vaccine?Recent advances in HIV research suggest the possibility that in the near future, daily antiretroviral therapy (ART) may no longer be needed to control HIV. For years, HIV researchers have... By Editorial Team3 min readBookmark for laterReactions 0 reactions Comments2 comments
Can Stigma Affect Viral Load Control in African American Women with HIV?Stigma can be a complicated and damaging experience for those who feel its effects. When someone is stigmatized, it means they are experiencing misjudgment, stereotyping, or negative attitudes from someone... By Editorial Team3 min readBookmark for laterReactions 0 reactions Comments1 comments
Are STI Rates Higher Among Daily PrEP Users?A study conducted in the Netherlands has found that the incidence of sexually transmitted infections (STIs) is higher among men who have sex with men (MSM) who take daily pre-exposure... By Editorial Team3 min readBookmark for laterReactions 0 reactions Comments2 comments
